Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by PoorOpinionon Mar 18, 2018 11:11am

97 Views

Post# 27735561

RE:RE:RE:RE:RE:RE:RE:RE:Why TH needs to trade in the US

SPCEO1 wrote:

I have a full stomach now, so I am less grumpy. But the valuation discrepancies are not something TH or its shareholders should just accept.

Starting to read the conversation.

I think you really should consider that these other biotechs are being valued on more than just their near-term revenue. I agree that Thera has little more than its near-term revenue to be valued on, while there is still some uncertainty here, its clearly under-valued and some of it (Europe, IM) is not valued at all.

I'm not unsympathetic with the NASDAQ idea. Other biotech/pharma have turned their back on Toronto. VBI vaccines is the latest, it just announced its delisting.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?